Insider Cluster (2 insiders) ·Filed Jul 14, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $723K total
Actionable Insight • Neutral

The insider selling is routine and immaterial relative to market cap. No actionable signal. Monitor for any upcoming earnings or news that might have prompted the option exercise, but the pattern suggests pre-planned 10b5-1 sales.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
UTHR ▼ -2.53% at T+20d
NEUTRAL call ✗ call lost -2.53% · α vs SPY -5.03% · entry $526.66 → $513.31
Next anchor: T+60d in 4d
Latest observation: T+55 +10.82% FF3 residual α
Entry anchored
Jul 13, 03:59 PM ET
via exchange tick
T+1d
+0.97%
call +0.97% · α +0.58%
$531.79
settled 3mo ago
T+5d
+0.51%
call +0.51% · α +1.80%
$529.34
settled 2mo ago
T+20d
-2.53%
call -2.53% · α -5.03%
$513.31
settled 8w ago
T+60d
—
call — · α —
—
in 4d

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt executed a series of option exercises and open-market sales totaling ~$9.4M over July 10-13, 2026, alongside a director sale of $179K. The total cluster sales of ~$9.6M represent only 0.04% of UTHR's $22.7B market cap, making this routine and immaterial insider activity.

Key Financial Metrics

Direction
selling
Total Value
$9.6M
Insiders
2

Key Facts

  • CEO Rothblatt exercised 19,000 options at $135.42 and sold 17,482 shares at ~$534-548, realizing ~$9.4M in proceeds.
  • Director Jan Malcolm sold 325 shares at $550.59 for $179K.
  • Total cluster open-market sales: ~$9.6M, or 0.04% of market cap.
  • Sales follow a typical cashless exercise pattern and are likely pre-planned under a 10b5-1 plan.

Financial Impact

CEO sold ~$9.4M in open-market sales following option exercises; total cluster sales of ~$9.6M represent 0.04% of market cap — immaterial.

insider sellingdilution from option exercises

Risk Factors

  • No material risk from insider activity; potential for further routine sales.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1784102551636
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 15, 2026